Clinical Trial Update: Safety & Efficacy of EPO-018B for the Treatment of Anemia in Participants With Chronic Kidney Diseases Not on Dialysis [Phase 2]

View source ↗

Summary

Phase 2 study update on EPO-018B for anemia in chronic kidney disease patients not on dialysis, highlighting safety and efficacy. The trial status is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• EPO-018B

Snippet

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Conditions: Chronic Renal Failure, Chronic Kidney Disease | Phase 2 | Status: UNKNOWN